Clinical and molecular characterization of chronic hepatitis B in Albania: A country that is still highly endemic for HBV infection

Journal of Medical Virology

Volumn 75, Issue 1, 2005, Pages 20-26

  Kondili, L A ^a,c   Brunetto, M R ^b   Maina, A M ^b   Argentini, C ^a   Chionne, P ^a   La Sorsa, V ^c   Resuli, B ^a   Mele, A ^a   Rapicetta, Maria ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

^c Depti i Semundjeve te Brendeshme   (Albania)

Author keywords

Anti HBe; BCP mutations; HBeAg; HBV DNA; Pre core mutation

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; NUCLEOTIDE; PROTHROMBIN; VIRUS DNA;

ADULT; AGED; ALBANIA; ARTICLE; CHRONIC HEPATITIS; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS B; HUMAN; HYBRIDIZATION; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MUTATION; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PREVALENCE; VIRUS GENOME;

ADULT; AGE FACTORS; AGED; ALBANIA; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; POINT MUTATION; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS); VIREMIA;

HEPATITIS B VIRUS;

EID: 9644268956     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20231     Document Type: Article

References (28)

1. Brunetto MR, Giarin MM, Oliveri F, Baldi EM, Alfarano A, Serra A, Saracco G, Verme G, Will H, Bonino F. 1991. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 88:4186-4190.
2. Brunetto MR, Cerenzia MT, Oliveri F, Piantino P, Randone A, Calvo PL, Manzini P, Rocca G, Galli C, Bonino F. 1993a. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 19:431-436.
3. Brunetto MR, Giarin M, Saracco G, Oliveri F, Calvo PL, Capra G, Randone A, Abate ML, Manzini P, Capalbo M. 1993b. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 105:845-850.
4. Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, Gorin JM, Bonino F. 2002. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: A long term cohort study. J Hepatol 36:263-270.
5. Chan HL, Leung NW, Hussain M, Wong ML, Lok AS. 2000. Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 31:763-768.
6. Chironna M, Germinario C, Lopalco PL, Quarto M, Barbuti S. 2000. HBV, HCV, and HDV infections in Albanian refugees in Southern Italy (Apulia region). Epidemiol Infect 125:163-167.
7. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS, Jr., Luketic VA, Terrault N, Lok AS, U.S. HBV Epidemiology Study Group. 2003. Prevalence of HBV precore/core promoter variants in the United States. Hepatology 38:619-628.
8. Colloredo G, Bellati G, Leandro G, Colombatto P, Rho A, Bissoli F, Brunetto MR, Angeli G, Ideo G, Bonino F. 1996. Quantitative analysis of IgM anti-HBc in chronic hepatitis B patients using a new "gray-zonequot; for the evaluation of "borderline" values. J Hepatol 25:644-648.
9. D'Amelio R, Stroffolini T, Nisini R, Matricardi PM, Rapicetta M, Spada E, Napoli A, Pasquini P. 1994. Incidence of hepatitis B virus infection among an Italian military population: Evidence of low infection spread. Eur J Epidemiol 10:105-107.
10. De Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, MeIe A, Paumgartner G, Pietrangelo A, Rodes J, Rosenberg W, Valla D, EASL Jury. 2003. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 39: S3-S25.
11. Funk ML, Rosenberg DM, Lok AS. 2002. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants. J Viral Hepatol 9:52-61.
12. Gaeta GB, Stornaiuolo G, Precone DF, Lobello S, Chiaramonte M, Stroffolini T, Colucci G, Rizzetto M. 2003. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 39:1036-1041.
13. Giusti G, Galanti B, Gaeta GB, Sagnelli E, Piccinino F, Ruggiero G. 1991. Clinical presentation and natural history of chronic persistent hepatitis. A multicentre retrospective study on 1197 cases. Ital J Gastroenterol 23:111-118.
14. Hadziyannis SJ. 1995. Hepatitis B e antigen negative chronic hepatitis B: From clinical recognition to pathogenesis and treatment. Viral Hepat Rev 1:7-36.
15. Hadziyannis SJ. 2002. Interferon alpha therapy in HBeAg-negative chronic hepatitis B: New data in support of long-term efficacy. J Hepatol 36:280-282.
16. Hall TA. 1999. BioEdit: A user-friendly biological sequence alignment editor and analysis Program for Windows 95/98/NT. Nucleic Acids Res 41:95-98.
17. Kidd-Ljunggren K, Miyakawa Y, Kidd AH. 2002. Genetic variability in hepatitis B viruses. J Gen Virol 83:1267-1280.
18. Kondili LA, Tosti ME, Szklo M, Costantino A, Cotichini R, Resuli B, Rapicetta M, Mele A. 1998. The relationships of chronic hepatitis and cirrhosis to alcohol intake, hepatitis B and C, and delta virus infection: A case-control study in Albania. Epidemiol Infect 121:391-395.
19. Lampertico P, Del Ninno E, Vigano M, Romeo R, Donate MF, Sablon E, Morabito A, Colombo M. 2003. Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy. Hepatology 37:756-763.
20. Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. 1999. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 179:775-782.
21. Lok AS, Heathcote EJ, Hoofnagle JH. 2001. Management of hepatitis B: 2000-Summary of a workshop. Gastroenterology 120:1828-1853.
22. Malamitsi-Puchner A, Papacharitonos S, Sotos D, Tzala L, Psichogiou M, Hatzakis A, Evangelopoulou A, Michalas S. 1996. Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol 12:297-301.
23. Mels GC, Bellati G, Leandro G, Brunetto MR, Vicari O, Borzio M, Piantino P, Fornaciari G, Scudeller G, Angeli G. 1994. Fluctuations in viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver 14:175-181.
24. Parekh S, Zoulim F, Ahn SH, Tsai A, Li J, Kawai S, Khan N, Trepo C, Wands J, Tong S. 2003. Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77:6601-6612.
25. Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J. 2002. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology 123:1848-1856.
26. Stroffolini T, Chiaramonte M, Craxi A, Franco E, Rapicetta M, Trivello R. 1991. Baseline sero-epidemiology of hepatitis B virus infection in children and teenagers in Italy. A survey before mass hepatitis B vaccination. J Infect 22:191-199.
27. Westland C, Delaney W IV, Yang H, Chen SS, Marcellin P, Hadziyannis S, Gish R, Fry J, Brosgart C, Gibbs C, Miller M, Xiong S. 2003. Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil1. Gastroenterology 125:107-116.
28. Yuen MF, Sablon E, Yuan HJ, Wong DK, Hui CK, Wong BC, Chan AO, Lai CL. 2003. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconvertion, cirrhosis-related complications, and hepatocellular carcinoma. Hepatology 37:562-567.